简短行为干预对肯尼亚城市有性别暴力史女性心理困扰的效果:一项随机临床试验
在肯尼亚内罗毕社区筛查有性别暴力史且心理困扰和功能受损的成年女性,随机分配接受由受训8天的社区工作者提供的5次问题管理plus(PM+)或社区护士提供的机构增强常规照护(EUC)。3个月随访时,PM+组在GHQ-12心理困扰改善上优于EUC组,差异为3.33(95%CI 1.86-4.79,P=0.001)。
要点
- PM+由受训8天的社区工作者在社区提供,共5次治疗。
- 3个月时PM+组GHQ-12改善较EUC组高3.33(95%CI 1.86-4.79,P=0.001)。
- PM+组PSYCHLOPS改善较EUC组高2.15(95%CI 0.98-3.32,P=0.001)。
核心结论
- 在肯尼亚城市有性别暴力史的女性社区样本中,与EUC相比,由非专业人员实施的简短行为干预在3个月随访时带来中等程度的心理困扰减少。
研究设计与样本
- 单盲、平行随机对照试验,在肯尼亚内罗毕通过社区筛查识别有性别暴力史且心理困扰和功能受损的成年女性。
- 参与者按1:1随机分配至PM+组(由接受8天培训的非专业社区工作者在社区提供)或EUC组(由社区护士提供的机构增强常规照护)。
- 共421名有性别暴力史的女性被随机分配,其中209名分配至PM+组,212名分配至EUC组;随访评估于2016年1月16日完成。
主要发现
- 主要分析为意向性治疗分析,PM+组53名(25%)和EUC组49名(23%)失访。
- 从基线至3个月,PM+组与EUC组在GHQ-12评分变化上的差异为3.33(95%CI 1.86-4.79,P=0.001),有利于PM+组。
- 从基线至3个月随访,PM+组与EUC组在WHODAS变化上的差异为1.96(95%CI 0.21-3.71,P=0.03),在PCL变化上的差异为3.95(95%CI 0.06-7.83,P=0.05),在PSYCHLOPS变化上的差异为2.15(95%CI 0.98-3.32,P=0.001),均有利于PM+组。
- GHQ-12评分的效应量为0.57(95%CI 0.32-0.83),PSYCHLOPS的效应量为0.67(95%CI 0.31-1.03),WHODAS的效应量为0.26(95%CI 0.02-0.50),PCL的效应量为0.21(95%CI 0.00-0.41)。
- 报告了12例不良事件,均为筛查期间检测到的自杀风险;没有不良事件归因于干预或试验。
局限性
- 研究局限性包括没有长期随访。
- 研究局限性包括依赖自我报告而非结构化访谈数据。
- 研究局限性包括缺乏注意力控制条件。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Gender-based violence (GBV) represents a major cause of psychological morbidity worldwide, and particularly in low- and middle-income countries (LMICs). Although there are effective treatments for common mental disorders associated with GBV, they typically require lengthy treatment programs that may limit scaling up in LMICs. The aim of this study was to test the effectiveness of a new 5-session behavioural treatment called Problem Management Plus (PM+) that lay community workers can be taught to deliver. METHODS AND FINDINGS: In this single-blind, parallel, randomised controlled trial, adult women who had experienced GBV were identified through community screening for psychological distress and impaired functioning in Nairobi, Kenya. Participants were randomly allocated in a 1:1 ratio either to PM+ delivered in the community by lay community health workers provided with 8 days of training or to facility-based enhanced usual care (EUC) provided by community nurses. Participants were aware of treatment allocation, but research assessors were blinded. The primary outcome was psychological distress as measured by the total score on the 12-item General Health Questionnaire (GHQ-12) assessed at 3 months after treatment. Secondary outcomes were impaired functioning (measured by the WHO Disability Adjustment Schedule [WHODAS]), symptoms of posttraumatic stress (measured by the Posttraumatic Stress Disorder Checklist [PCL]), personally identified problems (measured by Psychological Outcome Profiles [PSYCHLOPS]), stressful life events (measured by the Life Events Checklist [LEC]), and health service utilisation. Between 15 April 2015 and 20 August 2015, 1,393 women were screened for eligibility on the basis of psychological distress and impaired functioning. Of these, 518 women (37%) screened positive, of whom 421 (81%) were women who had experienced GBV. Of these 421 women, 209 were assigned to PM+ and 212 to EUC. Follow-up assessments were completed on 16 January 2016. The primary analysis was intention to treat and included 53 women in PM+ (25%) and 49 women in EUC (23%) lost to follow-up. The difference between PM+ and EUC in the change from baseline to 3 months on the GHQ-12 was 3.33 (95% CI 1.86-4.79, P = 0.001) in favour of PM+. In terms of secondary outcomes, for WHODAS the difference between PM+ and EUC in the change from baseline to 3-month follow-up was 1.96 (95% CI 0.21-3.71, P = 0.03), for PCL it was 3.95 (95% CI 0.06-7.83, P = 0.05), and for PSYCHLOPS it was 2.15 (95% CI 0.98-3.32, P = 0.001), all in favour of PM+. These estimated differences correspond to moderate effect sizes in favour of PM+ for GHQ-12 score (0.57, 95% CI 0.32-0.83) and PSYCHLOPS (0.67, 95% CI 0.31-1.03), and small effect sizes for WHODAS (0.26, 95% CI 0.02-0.50) and PCL (0.21, 95% CI 0.00-0.41). Twelve adverse events were reported, all of which were suicidal risks detected during screening. No adverse events were attributable to the interventions or the trial. Limitations of the study include no long-term follow-up, reliance on self-report rather than structured interview data, and lack of an attention control condition. CONCLUSIONS: Among a community sample of women in urban Kenya with a history of GBV, a brief, lay-administered behavioural intervention, compared with EUC, resulted in moderate reductions in psychological distress at 3-month follow-up. TRIAL REGISTRATION: Australian New Zealand Clinical Trials Registry ACTRN12614001291673.
引用
- Bryant RA, Schafer A, Dawson KS, et al. Effectiveness of a brief behavioural intervention on psychological distress among women with a history of gender-based violence in urban Kenya: A randomised clinical trial. PLoS Med. 2017. PMID: 28809935. doi:10.1371/journal.pmed.1002371
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。